Objective To review the principles of development of compound drugs for neurodegenerative diseases,summarize the related compound drugs developed in recent years and introduce their mechanism of action.Methods By searching relevant literature and databases at home and abroad,compound drugs and that have been developed or entered clinical trials and their mechanisms of action are summarized and analyzed.Results Significant progress has been made in the research on receptor suppressants,monoclonal antibody drugs,neuroprotective drugs and inflammatory suppressants.These drugs can improve memory and cognitive abilities through multi-target effects,significantly delay the progression of the disease,and bring new hopes for improving the quality of life of patients with neurodegenerative diseases and enhancing their motor function.Conclusion Compound drugs for treating neurodegenerative diseases have significant therapeutic advantages,but due to the complicated pathogenesis and irreversible course of disease,the development of these drugs remains challenging.The combination of emerging technologies such as bioinformatics technology,precision medicine,and nanodelivery systems can provide strong technical support and impetus of innovation for the development of compound drugs.
neurodegenerative diseasescompound drugsinflammation inhibitionneuroprotectionmulti-targetnanodelivery system
NETL
NSTL
万方数据
